ARS Pharmaceuticals
SPRY
SPRY
113 hedge funds and large institutions have $612M invested in ARS Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 36 increasing their positions, 27 reducing their positions, and 14 closing their positions.
Holders
113
Holders Change
+13
Holders Change %
+13%
% of All Funds
1.64%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.04%
New
27
Increased
36
Reduced
27
Closed
14
Calls
$6.42M
Puts
$1.02M
Net Calls
+$5.4M
Net Calls Change
+$3.76M
Top Buyers
1 |
RCM
1
RA Capital Management
Boston,
Massachusetts
|
$111M |
2 |
2
State Street
Boston,
Massachusetts
|
$16.4M |
3 |
PA
3
Perceptive Advisors
New York
|
$8.86M |
4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$29.5M |
5 |
5
Invesco
Atlanta,
Georgia
|
$4.2M |